1. 2006 A phase III multicenter trial comparing two different sequences of second/third line therapy (cetuximab/irinotecan followed by FOLFOX versus FOLFOX followed by cetuximab/irinotecan) in metastatic K-RAS wt colorectal cancer (mCC) patients, refractory to FOLFIRI/Bevacizumab). Issue 3 (September 2015) Authors: Cascinu, S.; Lonardi, S.; Rosati, G.; Nasti, G.; Zaniboni, A.; Romiti, A.; Aglietta, M.; Bilancia, D.; Iaffaioli, V.; Zagonel, V.; Giordano, M.; Corsi, D.; Ferraù, F.; Labianca, R.; Berardi, R.; Rulli, E.; Floriani, I. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB1211 IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS RECEIVING PD-1/PD-L1 INHIBITORS: PRELIMINARY RESULTS FROM A PROSPECTIVE COHORT STUDY. (2nd June 2020) Authors: Ferrarini, A.; Benfaremo, D.; Rossetti, G.; Morgese, F.; Tonnini, C.; Berardi, R.; Gabrielli, A.; Pomponio, G. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report. (December 2016) Authors: Ballatore, Z.; Pistelli, M.; Battelli, N.; Pagliacci, A.; Lisa, M.; Berardi, R.; Cascinu, S. Journal: BMC research notes Issue: Volume 9:Number 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers. (October 2019) Authors: Ruggeri, M.; Pagan, E.; Bagnardi, V.; Bianco, N.; Gallerani, E.; Buser, K.; Giordano, M.; Gianni, L.; Rabaglio, M.; Freschi, A.; Cretella, E.; Clerico, M.; Farolfi, A.; Simoncini, E.; Ciccarese, M.; Rauch, D.; Ramello, M.; Glaus, A.; Berardi, R.; Pellanda, A. Franzetti Journal: Breast Issue: Volume 47(2019) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019) Authors: Cazzaniga, M.E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferraù, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A.R.; Garrone, O.; Gebbia, V. Journal: Breast Issue: Volume 48(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis. (February 2017) Authors: De Lisi, D.; Maruzzo, M.; Galli, L.; Biasco, E.; Farnesi, A.; Procopio, G.; Ratta, R.; Buti, S.; Sternberg, C.N.; Cerbone, L.; Di Lorenzo, G.; Pantano, F.; Sterpi, M.; De Giorgi, U.; Berardi, R.; Torinai, M.; Camerini, A.; Massari, F.; Tonini, G.; Santini, D. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises. Issue 2 (February 2015) Authors: Massari, F.; Santoni, M.; Ciccarese, C.; Santini, D.; Alfieri, S.; Martignoni, G.; Brunelli, M.; Piva, F.; Berardi, R.; Montironi, R.; Porta, C.; Cascinu, S.; Tortora, G. Journal: Cancer treatment reviews Issue: Volume 41:Issue 2(2015) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗